Skip to content
Home/Companies/HealthTech/AmWell

AmWell

HealthTech·USA·Exited 2020·Held 2yr
Entry
2018
Hold
2yr
Exit
2020

Who owns AmWell?

AmWell is an American HealthTech company, formerly owned by Yaday, exited in 2020 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Yaday
Investor
Yaday
AA Sons Legacy · 2016 · VC

Key facts

HQUSA
SectorHealthTech
Exit Type
IPO
Buyer
NYSE IPO AMWL
Exit Year
2020

More from AA Sons Legacy

Other portfolio companies in the same fund.

Stage11
Stage11
Active
GamingFrance· 2022
Aeler
Aeler
Active
LogisticsSwitzerland· 2021
AnnaBella
AnnaBella
Active
ConsumerFrance· 2021
BodyVision Medical
BodyVision Medical
Active
HealthcareIsrael· 2021
Bruvi
Bruvi
Active
ConsumerUS· 2021
Cashbee
Cashbee
Active
FintechFrance· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns AmWell?

AmWell was formerly owned by Yaday, exited in 2020. No current private equity owner is on file.

Who did AmWell sell to?

Yaday sold AmWell to NYSE IPO AMWL in 2020 (IPO).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue